Virtual Programs dates and times will be published on or about April 15, 2021.
The DCAT Member Company Announcement Forum is an exclusive opportunity for senior executives at DCAT member companies to make major announcements to DCAT Week’s influential attendees and the industry press. For 2021, the DCAT Member Company Announcement Forum will be virtual. Pre-recorded video announcements by the selected companies will be available to the DCAT membership from July 12, 2021 through July 31, 2021 via the DCAT member portal.
Click here to learn more about how your company can apply for the 2021 DCAT Member Company Announcement Forum.
● Pharma Industry Outlook
DCAT’s Pharma Industry Outlook, presented annually at DCAT Week, is the most sought-after resource for Bio/Pharmaceutical market data and analysis providing you and your company a comprehensive, yet easy-to-digest analysis of industry performance crucial for your decision-making. Graham Lewis, Vice President of Global Pharma Strategy, IQVIA, a business intelligence firm regarded as the gold standard for Bio/Pharmaceutical market analysis, will provide comments on the latest market data and trends.
● Executives Insights: Manufacturing and Supply -
Lessons learned from the Pandemic
In meeting the immense challenge of developing COVID-19 vaccines and treatments, Bio/Pharmaceutical companies have had to meet the equally substantial task of manufacturing and supplying large volumes of vaccines and treatments under accelerated timelines. Hear from leading executives from Johnson & Johnson on its COVID-19 vaccine and Gilead Sciences for remdesivir, its small-molecule antiviral drug for treating COVID-19. This program will provide you and your company valuable insights on how you may optimize your supply strategies and practices.
● Executives Insights How COVID-19 is Transforming
the Future of Drug Development
Development of vaccines and treatments for COVID-19 has occurred at an unprecedented pace of scientific innovation. How was this done, and what does it mean for the future of drug development, manufacturing, and supply? Learn how Pfizer brought the first mRNA vaccine for COVID-19 to fruition, making it the first mRNA vaccine authorized for emergency use by the FDA. Plus, hear from National Resilience Inc., a new manufacturing and technology company led by former executives from Takeda and Roche/Genentech, which launched in November 2020 with initial capital of $800 million and a specific focus on manufacturing innovation.
● The CPO Lens What's Next in Business Continuity
Planning and Risk Mitigation
The Bio/Pharmaceutical industry has adapted its sourcing, procurement, and supply-management practices to adjust to the challenges arising from the COVID-19 pandemic, but where does the industry go from here? Learn whether your company is doing all it can do for supply assurance and whether it is at the forefront of industry change.
● DCAT Week Scientific Keynote Address
DCAT is honored to host Jennifer Doudna, Ph.D., Biochemist at the University of California, Berkeley, Founder of the Innovative Genomics Institute, Co-inventor of CRISPR technology, and Nobel Laureate in Chemistry (2020). Her groundbreaking development of CRISPR-Cas9 as a genome-engineering technology, with collaborator, Dr. Emmanuelle Charpentier, earned the two scientists the 2020 Nobel Prize in Chemistry and forever changed the course of human genomics research. The groundbreaking power and versatility of CRISPR-Cas9 have opened up new and wide-ranging possibilities across biology, agriculture, and medicine, including treating thousands of intractable diseases.
REGISTRATION FOR THESE PROGRAMS WILL OPEN IN MID-APRIL